Andy Goebel is a Group leader and postdoctoral researcher at Mildred Scheel Junior Center for Cancer Research. He completed his education at the Dresden University of Technology. His clinical interests are Molecular Biology, Endocrinology, Diabetes, Bone Disorders, Protein Expression, Cell Culture, Cancer Biology, Immunohistochemistry, Cancer Biomarkers, Apoptosis, and Cell Signaling.